Synageva BioPharma Submits Kanuma (Sebelipase Alfa) Application For LAL Deficiency In Japan
May 26, 2015 at 16:06 PM EDT
Synageva BioPharma Corp. (NASDAQ: GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, today ...